Cannabis and Breastfeeding
THC transfers into breast milk reliably; long-term infant effects remain unclear.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
The good news: we have solid data on THC's pharmacokinetics in milk. The honest news: we don't have robust long-term outcome studies. Major health bodies recommend abstaining, which is reasonable given the unknowns. If you're considering use, the conversation should be evidence-based, not reflexively alarmist. Dose, frequency, and your individual risk tolerance matter.
Not medical advice
This article is not medical advice. It summarizes published research and official guidance for educational purposes only. If you are breastfeeding or considering cannabis use during lactation, talk to a clinician you trust — ideally one who will discuss the topic without judgment so you get accurate information rather than reflexive disapproval. This article does not replace individualized clinical consultation.
Plain-language summary
THC, the main psychoactive compound in cannabis, is fat-soluble. Breast milk is fatty. Therefore, THC concentrates in milk Strong evidence [1][2]. Infants who nurse from a parent using cannabis do absorb measurable THC and its metabolites Strong evidence [2][3].
Whether that exposure causes meaningful harm is the unsettled question. A handful of older studies suggested motor development differences at one year Weak / limited [4], but the research base is small, the confounders (tobacco co-use, prenatal exposure, socioeconomic factors) are substantial, and no modern well-powered studies have definitively answered this Weak / limited.
Major health bodies — the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics, the CDC, and the WHO — recommend abstaining from cannabis while breastfeeding [5][6][7]. That recommendation is grounded in the precautionary principle: because long-term effects are not well-characterized, avoidance is the conservative choice. It is not based on documented harm in typical use.
What is established: pharmacokinetics
The strongest evidence base concerns how THC moves into and persists in breast milk.
THC concentrations in milk exceed maternal plasma levels. Because THC is lipophilic (fat-loving), it preferentially partitions into the fatty fraction of milk. Bertrand et al. (2018) measured THC in milk samples from regular users and found detectable concentrations persisting for days after use Strong evidence [1].
Infants absorb cannabinoids from milk. Baker et al. (2018) detected THC and cannabinoid metabolites in urine and stool samples from nursing infants whose parents used cannabis Strong evidence [2].
Pumping and dumping does not meaningfully accelerate THC clearance. This is a common misconception. THC is stored in body fat and released slowly; dumping expressed milk does not clear the compound from your system or breast tissue Strong evidence [2]. THC clearance is determined by metabolism and fat redistribution, not by milk expression.
Timing of feeds relative to use has limited effect. Some practitioners recommend nursing immediately after use to maximize the interval before the next feed. While mechanistically sensible, the multi-day half-life of THC in milk means that the time gain is modest Weak / limited [2].
If the core question is "does cannabis use expose my infant to cannabinoids," the answer is yes, reliably and measurably.
What might work but is unproven
Reducing frequency reduces infant exposure. Lowering use frequency logically reduces the cumulative THC dose an infant receives. However, no peer-reviewed studies have quantified dose-response relationships in nursing dyads, so we cannot define a "safe" frequency or amount Weak / limited.
CBD-only products. Isolated CBD is plausible as a lower-risk alternative to THC-containing products because CBD is not psychoactive and has not been linked to the same neurodevelopmental concerns. However, human lactation data for CBD is essentially absent No data [8]. Additionally, the unregulated CBD market has well-documented contamination with THC, heavy metals, and other cannabinoids, making product verification difficult Strong evidence [8].
Route of administration. Some suggest that different routes (smoking, edibles, tinctures) might confer different risks to a nursing infant. The route does alter maternal pharmacokinetics; however, all routes ultimately deliver cannabinoids into the bloodstream and therefore into milk. No evidence shows that one route is meaningfully safer for the infant than another No data.
What does not work: common misconceptions
Pump and dump to clear THC. This is a widespread misconception and does not work. THC clearance is governed by your metabolism and body fat stores, not by emptying your breasts Strong evidence [2].
"It's natural, so it's safe." Naturalness is not a safety argument. Alcohol, nicotine, and many plant toxins are natural and all transfer into breast milk with documented effects. Naturalness does not equal safety in lactation.
Strain type (indica vs sativa) matters for breastfeeding. The indica/sativa botanical distinction is largely marketing folklore and has no relevance to cannabinoid transfer into milk. THC and other cannabinoids are produced by both phenotypes and transfer into milk regardless of strain designation.
What we genuinely don't know
This section reflects the major evidence gaps.
Long-term neurodevelopmental outcomes. The most commonly cited study is Astley & Little (1990), which reported motor development differences at 12 months in infants exposed via breast milk [4]. However, the sample was small (68 exposed, 66 unexposed), and confounders were substantial: maternal tobacco use, prenatal exposure to cannabis, and socioeconomic factors were not adequately controlled Weak / limited [4]. No adequately powered prospective cohort study has replicated or refuted these findings since publication.
Dose-response relationships. We do not know how much THC exposure via milk, over what duration, produces detectable developmental or behavioral effects. There is no established safe threshold or minimum-risk frequency No data.
CBD in lactation. Isolated CBD products have virtually no published human lactation data No data [8].
Occasional use. Most clinical and research observations come from regular or heavy users. We have very limited data on infants whose parents use cannabis infrequently (e.g., once monthly) No data.
Confounding in observational studies. Cannabis users are more likely to also use tobacco, alcohol, or other substances. Disentangling which exposures drive any observed effects is difficult in observational research Weak / limited.
Effects of maternal anxiety or depression on breastfeeding outcomes. If cannabis use reflects untreated postpartum mood disorder, maternal mental health may confound any apparent infant effects. This has not been systematically studied No data.
Standard treatments with better-characterized lactation profiles
Breastfeeding parents use cannabis postpartum for several indications. For each, standard treatments have more extensive lactation safety data:
Postpartum depression and anxiety: Sertraline and several other SSRIs have extensive clinical lactation data and are considered compatible with breastfeeding by LactMed (the NIH lactation database) [9]. Long-term follow-up studies exist.
Sleep and insomnia: Behavioral approaches (sleep hygiene, cognitive behavioral therapy for insomnia) are first-line. Short-acting sedatives such as zolpidem have lactation data, though long-term use is generally not recommended [9].
Pain: Ibuprofen and acetaminophen are well-characterized in lactation with extensive safety data in breastfeeding populations [9].
Nausea and vomiting: Ondansetron, metoclopramide, and other antiemetics have established lactation profiles [9].
Fatigue: Behavioral and sleep-based approaches; evaluation for underlying anemia, thyroid dysfunction, or postpartum depression is standard.
None of this implies that cannabis is uniquely dangerous compared to other drugs. It means that for most common postpartum symptoms, there are options where we actually know what happens to the infant. The LactMed database (free and run by the NIH at https://www.ncbi.nlm.nih.gov/books/NBK501922/) is the best single resource for looking up specific medications and their lactation profiles [9].
Documented and plausible risks
Documented risks:
- Infant exposure to THC and cannabinoid metabolites via breast milk Strong evidence [1][2].
- Prolonged detectability of THC in milk and infant samples days after parental use Strong evidence [2].
Plausible but unproven risks:
- Subtle motor or cognitive development effects with chronic heavy prenatal and/or postnatal exposure Weak / limited [4]. The mechanistic basis is the presence of cannabinoid receptors in developing brain, but causality has not been established in humans.
Not documented in nursing-specific literature:
- Acute toxicity, overdose, or hospitalization in infants from typical breast milk exposure alone No data. Acute infant cannabis toxicity cases reported in the medical literature generally involve direct ingestion of edibles, not nursing exposure.
Legal and custodial risk:
- In many jurisdictions, a positive drug screen in an infant or nursing parent can trigger involvement by child protective services regardless of the medical risk assessment. This is a real social consequence worth understanding, independent of the biology Strong evidence [10].
Bottom line and harm reduction
The conservative recommendation to abstain from cannabis while breastfeeding is reasonable given the unknowns. However, the evidence does not support claims that occasional use causes definite harm, nor does it support claims that use is definitely safe.
If you decide to use cannabis while breastfeeding, harm-reduction basics include:
- Minimize frequency. Lower use frequency reduces cumulative infant exposure, though the magnitude of benefit is unquantified.
- Avoid high-potency concentrates. Concentrate products (dabbing, vaping distillate) deliver much higher THC doses than whole-flower use and would logically increase milk concentrations and infant exposure.
- Be honest with your pediatrician or healthcare provider. Pediatricians need to know your substance use to monitor appropriately, and the conversation should not be adversarial. Bring this article with you if it helps.
- Know your jurisdiction's drug-testing and child welfare policies. Understand the legal and custodial implications where you live.
- Explore alternatives for the symptom you are treating. If you are using cannabis for sleep, anxiety, or pain, consider whether a standard treatment with better lactation data might fit your situation.
This is a decision that balances incomplete pharmacological knowledge, personal values, and local legal context. Neither blanket prohibition nor unconditional permission is supported by the evidence.
Sources
- Peer-reviewed Bertrand KA, Hanan NJ, Honerkamp-Smith G, Best BM, Chambers CD. (2018). Marijuana Use by Breastfeeding Mothers and Cannabinoid Concentrations in Breast Milk. Pediatrics, 142(3), e20181076.
- Peer-reviewed Baker T, Datta P, Rewers-Felkins K, Thompson H, Kallem RR, Hale TW. (2018). Transfer of Inhaled Cannabis Into Human Breast Milk. Obstetrics & Gynecology, 131(5), 783–788.
- Peer-reviewed Moran VH, Dykes F, Edwards DJ. (2017). A Systematic Review of the Evidence for Cannabis Use During Pregnancy and Lactation. Breastfeeding Medicine, 12(10), 1–8.
- Peer-reviewed Astley SJ, Little RE. (1990). Maternal Marijuana Use During Lactation and Infant Development at One Year. Neurotoxicology and Teratology, 12(2), 161–168.
- Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstetrics & Gynecology, 130(4), e205–e209. (2017).
- Peer-reviewed Ryan SA, Ammerman SD, O'Connor ME, American Academy of Pediatrics Committee on Substance Use and Prevention. (2018). Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes. Pediatrics, 142(3), e20181889.
- Government Centers for Disease Control and Prevention. (2024). Marijuana and Public Health: Pregnancy and Breastfeeding.
- Government U.S. Food and Drug Administration. (2019). What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding.
- Government National Library of Medicine. (2024). LactMed: Drugs and Lactation Database. Bethesda, MD: National Institute of Child Health and Human Development.
- Peer-reviewed Roberts SCM, Nuru-Jeter A. (2012). Universal Screening for Alcohol and Drug Use and Racial Disparities in Child Protective Services Reporting. Journal of Behavioral Health Services & Research, 39(1), 3–16.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Nausea — Cannabinoids reduce chemotherapy nausea; evidence is weak for other causes.
- Cannabis and Neuropathic Pain — Modest efficacy for some neuropathic pain types; best evidence is short-term and third-lin...
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.